The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Serum Aldosterone Concentration and Cardiovascular Risk in Women with Polycystic Ovarian Syndrome
Abstract
Context: Polycystic ovary syndrome (PCOS) is associated with early impairment of vascular structure and a low-grade chronic inflammation. Aldosterone is a well-recognized cardiovascular risk (CVR) factor and is related to inflammatory processes. Objective: Our objective was to investigate serum aldosterone levels in PCOS and correlate them to some CVR factors and early atherosclerotic markers. Design and Setting: A prospective baseline-controlled clinical study was conducted at the University “Federico II” of Naples School of Medicine (Naples, Italy). Patients: Fifty PCOS women age- and body mass index-matched with 50 healthy women were enrolled. Mean Outcome Measures: Anthropometric, hormonal, and metabolic patterns, including plasma aldosterone, renin, and C-reactive protein, were measured in each subject. Intima-media thickness was also evaluated in each patient and control. Results: Aldosterone levels were significantly increased (P < 0.001) in PCOS compared with healthy women (10.5 ± 3.2 vs. 5.7 ± 2.5 ng/dl). In PCOS, a significant (P < 0.001) direct correlation between plasma aldosterone and homeostasis model assessment, C-reactive protein, intima-media thickness, and mean blood pressure was found. On the other hand, high-density lipoprotein cholesterol and potassium were inversely (P < 0.001) related to serum aldosterone. Multiple linear regression analysis showed that the area under the curve for insulin and homeostasis model assessment was linearly related to aldosterone in PCOS. Conclusion: PCOS women show an insulin resistance related increase in serum aldosterone levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that aldosterone is the main proinflammatory hormone and, unfortunately, the use of COCs stimulates the synthesis of angiotensinogen and activates the renin–angiotensin–aldosterone system (RAAS) [13,14,68].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [68]
In the citing paper
“It is known that aldosterone is the main proinflammatory hormone and, unfortunately, the use of COCs stimulates the synthesis of angiotensinogen and activates the renin–angiotensin–aldosterone system (RAAS) [13,14,68].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Men at risk: occupation and male infertility.
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219
Swedberg, K. B., Eneroth, P. H. E., KJEKSHUS, J. K., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,147
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703
Low grade chronic inflammation in women with polycystic ovarian syndrome
Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640
DeUgarte, C. M., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.070 · Cited by 589
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 573
Gabir, M. M., Hanson, R. L., Dabelea, D., Imperatore, G., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1108 · Cited by 568
Azziz, R., Marin, C., Hoq, L., Badamgarav, E., & Song, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0628 · Cited by 537
Farquharson, C. A. J., & Struthers, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.6.594 · Cited by 527
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–120 of 120
Marcadores precoces de doença cardiovascular em mulheres com síndrome dos ovários policísticos
Soares, G. M. (2008) · doi:10.11606/d.17.2008.tde-26092013-164044 · Cited by 1
Risco de Farmingham e evento cardiovascular em mulheres com síndrome dos ovários policísticos
Santos, A. G. (2014) · Americanae (AECID Library) · Cited by 1
Corticosteroid hormone action in the cardiovascular system
Hammer, F. (2011) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Chen, M., & Yang, Y. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.093906
Tratamiento del síndrome de ovario poliquístico: Anticonceptivos orales
Cabrera, M., Centeno, I., & Nottola, N. (2007) · Revista Venezolana de Endocrinología y Metabolismo
Lopes, I. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-17042018-154801
Philbois, S. V. (2018) · doi:10.11606/d.17.2018.tde-26042018-115231
Ribeiro, V. B. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-01022019-101328
Zhuang, C., Wang, Q., Wang, W.-J., Sun, R., Zhang, X., & Yu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-230193/v1
(2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f37e31
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3281de7489
Stracquadanio, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29223-2_4
Cardiovascular risk reduction in polycystic ovary syndrome
Shams, P., Ahmed, I., & Samad, Z. Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00027-x
Scott, H. C., Philpott, M., Berridge, G., Yu, Z., O'Brien, D. P., Becker, C., Lindgren, C. M., Oppermann, U. C. T., Müller, J., Fritsch, M., et al. (2025) · Journal of Endocrinology and Metabolism · doi:10.14740/jem1042
Metabolomic Analysis of Serum in Polycystic Ovary Syndrome Patients with Insulin ResistancePreprint
Lixing, L., Lin, P., Lixi, C., Zhang, M., & Chen, X. (2025) · Research Square · doi:10.21203/rs.3.rs-6668120/v1
Risk of Cardiovascular Disease among Women with PCOS
Chopra, A., & Bhattacharya, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810962125010013
王, 月. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.162501
Naveed, M., Yang, T., Togliatti, O., Joe, B., & Hill, J. W. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10085-y
Metadata
- Authors
- Cascella, T., Palomba, S., Tauchmanovà, L., Manguso, F., Di Biase, S., Labella, D., Giallauria, F., Vigorito, C., Colao, A., Lombardi, G., & Orio, F.
- Affiliations
- University of Naples Federico II (IT)
- Magna Graecia University (IT)
- Department of Molecular and Clinical Endocrinology and Oncology (T.C., L.T., A.C., G.L., F.O.),” 80131 Naples, Italy
- MeriGen Laboratory of Molecular Biology (S.D.B., D.L.), 80131 Naples, Italy
- Federico II University Hospital (IT)
- Corresponding author
- Orio, Francesco
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-11-01
- Volume
- 91
- Issue
- 11
- Pages
- 4395-4400
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090608637
- Cited by
- 120
- References
- 48
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 10 · 2019: 9 · 2018: 6 · 2017: 1 · 2016: 4 · 2015: 5 · 2014: 5 · 2013: 6 · 2012: 7
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, serum aldosterone, cardiovascular risk, insulin resistance, intima-media thickness, C-reactive protein, renin, atherosclerosis, HOMA, blood pressure, HDL cholesterol, potassium, women
- MeSH terms
- Adult, Aldosterone, Cardiovascular Diseases, Female, Humans, Polycystic Ovary Syndrome, Prospective Studies, Risk Factors, Causality, Case-Control Studies, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
